The association “Medicine companies in Morocco” announces, this Tuesday, November 22, that its members have elected a new executive office during its general assembly.
November 22, 2022 at 2:15 p.m.
Modified November 22, 2022 at 2:41 p.m.
The association “Medicine companies in Morocco” announces, this Tuesday, November 22, that its members have elected a new executive office during its general assembly.
“For the first time, a Moroccan will represent the international biopharmaceutical sector”, highlights a press release from the association “Medicine companies in Morocco” (LEMM). The composition of the new board is as follows:
– President: Myriem Tamimy, general manager of the company GSK ;
– Vice-presidents: companies Roche, Sanofi and MSD represented by their managing directors, respectively Sanaa Sayagh, Amine Benabderrazik and Alain Barry;
– General Secretary: Mehdi Seqat, General Manager of the company Janssen ;
– Treasurer: Amine Sekhri, CEO ofAstraZeneca ;
– Finally, the executive director is Fadela Benjelloun.
LEMM is a professional association bringing together 18 active members, Moroccan subsidiaries of international pharmaceutical groups.
November 22, 2022 at 2:15 p.m.
Modified November 22, 2022 at 2:41 p.m.
